NCT00992095View on ClinicalTrials.gov

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Opioid-Related Disorders
Interventions
DRUG

buprenorphine hydrochloride

single dose 8 mg sublingual tablet

Trial Locations (1)

78759

CEDRA Clinical Research, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00992095 - Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions | Biotech Hunter | Biotech Hunter